Eric Risser
Chief Operating Officer chez MACROGENICS, INC.
Fortune : 572 608 $ au 31/03/2024
Profil
Eric Risser's current job is as the Chief Operating Officer at MacroGenics, Inc. He previously worked as the Senior Director-Business Development at Johnson & Johnson Pharmaceutical Group from 2003 to 2009.
Eric also has experience as a Venture Capitalist at Scale Management LLC and as an Investment Banker at Lehman Brothers Ltd.
He holds an MBA from Stanford University and completed his undergraduate studies at Yale University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MACROGENICS, INC.
0,06% | 04/03/2024 | 38 900 ( 0,06% ) | 572 608 $ | 31/03/2024 |
Postes actifs de Eric Risser
| Sociétés | Poste | Début |
|---|---|---|
| MACROGENICS, INC. | Chief Operating Officer | 22/02/2022 |
Anciens postes connus de Eric Risser
| Sociétés | Poste | Fin |
|---|---|---|
| Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | 01/01/2009 |
| Lehman Brothers Ltd. | Corporate Officer/Principal | - |
Scale Management LLC
 Scale Management LLC Investment ManagersFinance Scale Management LLC (Scale Management) is a venture capital firm founded in 1995 by Kate D. Mitchell and Anchie Y. Kuo. The firm is headquartered in Foster City, California. | Corporate Officer/Principal | - |
Formation de Eric Risser
| Stanford University | Masters Business Admin |
| Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MACROGENICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Scale Management LLC
Scale Management LLC Investment ManagersFinance Scale Management LLC (Scale Management) is a venture capital firm founded in 1995 by Kate D. Mitchell and Anchie Y. Kuo. The firm is headquartered in Foster City, California. | Finance |
| Johnson & Johnson Pharmaceutical Group | |
| Lehman Brothers Ltd. |
